231-639-5 | Sigma-Aldrich

Data Sheet - SAB4200093

. Biol. Chem., 279, 37470-37476 (2004). 5. Meller, N., et al., J. Cell Sci., 118, 4937-4936 (2005). 6. Meller, N., et al., Nat. Cell Biol., 4, 639-647 (2002). 7. Meller, N., et al., Biochem.

TB375 pTK-neo Plasmid Map

AccI 1 332 EcoO109I 2 309 2042 AatII Acc65I AclI AfeI AgeI AflII 2 26 150 EcoRI 1 639 AhdI AleI AloI ApaI AscI

XP725 Antibody Number-Lot Number 071M4826

587 588 609 610 611 612 633 634 635 636 657 658 659 660 7.4 589 590 591 592 613 614 615 616 637 638 639 640 661 662 663 664 7.5 593 594 595 596 617 618 619 620 641 642

ApopTag® Fluorescein Direct In Situ Apoptosis Detection Kit

transferase and nick translation assays and prevention by serine protease inhibitors. Int. J. Oncol. 1: 639-648. 17. Gorczyca, W., J. Gong and Z. Darzynkiewicz. (1993) Detection of DNA strand breaks in

ApopTag® Red In Situ Apoptosis Detection Kit

transferase and nick translation assays and prevention by serine protease inhibitors. Int. J. Oncol. 1: 639-648. 17. Gorczyca, W., J. Gong and Z. Darzynkiewicz. (1993) Detection of DNA strand breaks in

ApopTag® Plus Peroxidase In Situ Apoptosis Detection Kit

transferase and nick translation assays and prevention by serine protease inhibitors. Int. J. Oncol. 1: 639-648. 17. Gorczyca, W., J. Gong and Z. Darzynkiewicz. (1993) Detection of DNA strand breaks in

ApopTag® Peroxidase In Situ Apoptosis Detection Kit

transferase and nick translation assays and prevention by serine protease inhibitors. Int. J. Oncol. 1: 639-648. 17. Gorczyca, W., J. Gong and Z. Darzynkiewicz. (1993) Detection of DNA strand breaks in

Research Article: MCP-1, KC-like and IL-8 as critical mediators of

1957 10–6502 1–2106 12–5436 2–2278 163–1921 Median 182 532 96 101 856 560 160 188 390 SD 176 639 525 378 1541 421 1032 487 494 p-value < 0.0001 < 0.0001 < 0.0001 0.019 < 0.0001 <

XP725 Antibody List Lot 129K4831

P0713 18762 Prkcz P NP_001034168.1 n/d y y 597 Prion Protein P5999 19122 Prnp M NP_035300.1 n/d y y 639 Reelin R4904 19699 Reln P NP_035391.2 n/d y y 699 a1 Syntrophin S4813 20648 Snta1 P NP_033254.2 n/d

XP725 Antibody List Lot 129K4830

P0713 18762 Prkcz P NP_001034168.1 n/d y y 597 Prion Protein P5999 19122 Prnp M NP_035300.1 n/d y y 639 Reelin R4904 19699 Reln P NP_035391.2 n/d y y 699 a1 Syntrophin S4813 20648 Snta1 P NP_033254.2 n/d

XP725 Antibody List Lot 089K4791

P0713 18762 Prkcz P NP_001034168.1 n/d y y 597 Prion Protein P5999 19122 Prnp M NP_035300.1 n/d y y 639 Reelin R4904 19699 Reln P NP_035391.2 n/d y y 699 a1 Syntrophin S4813 20648 Snta1 P NP_033254.2 n/d

Cytoskeletal Signaling Antibodies, Reagents and Kits

Rb IgG 200 µL 07-231 Anti-mTOR, a.a. 1223-1290 H R IP WB Pur Rb 100 µg AB3882 Anti-phospho-mTOR (Ser2448) M WB APur Rb 100 µg 09-213 siRNA siRNA plasmid, pKD-mTOR-v4, H RNAi 5 mg 62-302

New Products - Volume 1, 2013: Antibodies, Assays, Small Molecules, Inhibitors, and Proteins

Gavathiotis, E., Reyna DE, Bellairs, JA, Leshchiner ES, and Walensky LD. (2012). Nat. Chem. Biol. 8, 639-645. PUBlICATION HIGHlIGHT ON sMAll MOlECUlEs: For publications on using these small molecules

Advanced Applications of Engineered Nanomaterials

25 mg in 5 mL toluene) 590 595 - 611 24 4.0-4.3 2.5 ~50% CdSe 610 Dispersion (25 mg in 5 mL toluene) 610 518 - 627 25 4.7-5.2 3.7 ~50% CdSe 640 Dispersion (25 mg in 5

List of Antibodies

y y n/d 636 PIASy P0104 M y n/d n/d 637 RAP1 R8154 M y n/d n/d 638 RbAp48/RbAp46 R3779 P y n/d n/d 639 Reelin R4904 P n/d y y 640 Retinoblastoma R6775 P y n/d n/d 641 phospho-Retinoblastoma (pSer795) R6878

XP725 Worksheet for Lot Number 071M4826

228 2 1 5 4 Caspase 3 Active C8487 229 2 1 5 5 Caspase 4 C4481 230 2 1 5 6 Caspase 4 C4481 231 2 1 5 7 Caspase 4 C3392 232 2 1 5 8 Caspase 4 C3392 233 2 1 6

Halal Certificate

C32919 HC-24SITE68 638. EVENING PRIMROSE OIL, CERTIFIED ORGANIC (NOP) W530165 A75717 HC-24SI6T79 639. FARNESENE, MIXTURE OF ISOMERS W383902 C37190 HC-24SIBY35 640. FARNESOL MIXTURE OF ISOMERS, 95%

Halal Certificate

C32919 HC-22SIB166 638. EVENING PRIMROSE OIL, CERTIFIED ORGANIC (NOP) W530165 A75717 HC-22SIYE77 639. FARNESENE, MIXTURE OF ISOMERS W383902 C37190 HC-22SIUZ33 640. FARNESOL MIXTURE OF ISOMERS, 95%

XP725 Antibody List

Rbbp7,RBBP4,Rbbp4,Rbbp4_predicted NP_033056.2,NP_002884.1,NP_005601.1,NP_033057.3,NP_00 P y n/d n/d 639 Reelin R4904 24718, 19699 Reln NP_536319.2,NP_035391.2 P n/d y y 640 Retinoblastoma R6775 5925 RB1

XP725 Antibody List 013M4793

Rbbp4,Rbbp4_predict NP_033056.2,NP_002884.1,NP_005601.1,NP_033057.3,NP_001101382.1,NP_11 P y n/d n/d 639 Reelin R4904 24718, 19699 Reln NP_536319.2,NP_035391.2 P n/d y y 640 Retinoblastoma R6775 5925 RB1